1. Home
  2. CBL vs CDMO Comparison

CBL vs CDMO Comparison

Compare CBL & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • CDMO
  • Stock Information
  • Founded
  • CBL 1978
  • CDMO 1981
  • Country
  • CBL United States
  • CDMO United States
  • Employees
  • CBL N/A
  • CDMO N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • CDMO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBL Real Estate
  • CDMO Health Care
  • Exchange
  • CBL Nasdaq
  • CDMO Nasdaq
  • Market Cap
  • CBL 813.3M
  • CDMO 784.1M
  • IPO Year
  • CBL 1993
  • CDMO N/A
  • Fundamental
  • Price
  • CBL $27.25
  • CDMO $12.15
  • Analyst Decision
  • CBL
  • CDMO Buy
  • Analyst Count
  • CBL 0
  • CDMO 5
  • Target Price
  • CBL N/A
  • CDMO $13.63
  • AVG Volume (30 Days)
  • CBL 103.4K
  • CDMO 3.6M
  • Earning Date
  • CBL 11-11-2024
  • CDMO 12-05-2024
  • Dividend Yield
  • CBL 5.87%
  • CDMO N/A
  • EPS Growth
  • CBL N/A
  • CDMO N/A
  • EPS
  • CBL 1.01
  • CDMO N/A
  • Revenue
  • CBL $523,580,000.00
  • CDMO $142,358,000.00
  • Revenue This Year
  • CBL N/A
  • CDMO $19.31
  • Revenue Next Year
  • CBL N/A
  • CDMO $21.14
  • P/E Ratio
  • CBL $26.97
  • CDMO N/A
  • Revenue Growth
  • CBL N/A
  • CDMO N/A
  • 52 Week Low
  • CBL $20.97
  • CDMO $4.07
  • 52 Week High
  • CBL $28.50
  • CDMO $12.48
  • Technical
  • Relative Strength Index (RSI)
  • CBL 55.53
  • CDMO 67.73
  • Support Level
  • CBL $25.92
  • CDMO $11.67
  • Resistance Level
  • CBL $28.50
  • CDMO $12.30
  • Average True Range (ATR)
  • CBL 0.57
  • CDMO 0.27
  • MACD
  • CBL -0.04
  • CDMO 0.17
  • Stochastic Oscillator
  • CBL 51.55
  • CDMO 89.03

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Share on Social Networks: